MiR-182 affects renal cancer cell proliferation, apoptosis, and invasion by regulating PI3K/AKT/mTOR signaling pathway.
- DOI
- 10.26355/eurrev_201801_14179
- Published
- 2018 Jan
- Container
- European review for medical and pharmacological sciences
- Publisher
- Not recorded
- Open access
- no
Credibility signals
serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.26355/eurrev_201801_14179,
title = {MiR-182 affects renal cancer cell proliferation, apoptosis, and invasion by regulating PI3K/AKT/mTOR signaling pathway.},
author = {Fu JH and Yang S and Nan CJ and Zhou CC and Lu DQ and Li S and Mu HQ},
year = {2018},
journal = {European review for medical and pharmacological sciences},
doi = {10.26355/eurrev_201801_14179},
url = {https://doi.org/10.26355/eurrev_201801_14179}
}RIS
TY - JOUR TI - MiR-182 affects renal cancer cell proliferation, apoptosis, and invasion by regulating PI3K/AKT/mTOR signaling pathway. AU - Fu JH AU - Yang S AU - Nan CJ AU - Zhou CC AU - Lu DQ AU - Li S AU - Mu HQ PY - 2018 JO - European review for medical and pharmacological sciences DO - 10.26355/eurrev_201801_14179 UR - https://doi.org/10.26355/eurrev_201801_14179 ER -
APA
JH, F., S, Y., CJ, N., CC, Z., DQ, L., S, L., & HQ, M. (2018). MiR-182 affects renal cancer cell proliferation, apoptosis, and invasion by regulating PI3K/AKT/mTOR signaling pathway.. European review for medical and pharmacological sciences. https://doi.org/10.26355/eurrev_201801_14179
Source records
- pubmed · retrieved 2026-09-25T03:55:52.460Z
- europe-pmc · retrieved 2026-09-25T03:55:52.506Z